Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edmond FitzGibbon

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
American Journal of Medical Genetics. Part A|January 4, 2020
White vitreous opacities in five patients with Gaucher disease type 3Gurpreet K Seehra, Areian Eghbali, Ellen Sidransky, et al.
Molecular Genetics and Metabolism|May 4, 2019
Ophthalmological findings in Gaucher diseaseAreian Eghbali, Shahzeb Hassan, Gurpreet Seehra, et al.
The New England Journal of Medicine|November 22, 2002
Normal vision despite narrowing of the optic canal in fibrous dysplasiaJanice S Lee, Edmond FitzGibbon, John A Butman, et al.
Pediatric Transplantation|July 29, 2005
Idiopathic intracranial hypertension following kidney transplantation: a case report and review of the literatureChristine E Chamberlain, Edmond Fitzgibbon, Eric M Wassermann, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2021
Survivorship Issues in Adult Patients With Histiocytic NeoplasmsKevin O'Brien, Rahul Dave, Skand Shekhar, et al.
Ophthalmology|June 25, 2021
ReplyM Teresa Magone, Iris R Hartley, Edmond FitzGibbon, et al.
Ophthalmology|September 5, 2020
Ocular Adverse Effects of Infigratinib, a New Fibroblast Growth Factor Receptor Tyrosine Kinase InhibitorM Teresa Magone, Iris R Hartley, Edmond Fitzgibbon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 31, 2020
Outcomes in Previously Healthy Cryptococcal Meningoencephalitis Patients Treated With Pulse Taper Corticosteroids for Post-infectious Inflammatory SyndromeSeher Anjum, Owen Dean, Peter Kosa, et al.
JAMA|March 18, 2024
Clinical, Biomarker, and Research Tests Among US Government Personnel and Their Family Members Involved in Anomalous Health IncidentsLeighton Chan, Mark Hallett, Chris K Zalewski, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
American Journal of Medical Genetics. Part A|January 4, 2020
White vitreous opacities in five patients with Gaucher disease type 3Gurpreet K Seehra, Areian Eghbali, Ellen Sidransky, et al.
Molecular Genetics and Metabolism|May 4, 2019
Ophthalmological findings in Gaucher diseaseAreian Eghbali, Shahzeb Hassan, Gurpreet Seehra, et al.
The New England Journal of Medicine|November 22, 2002
Normal vision despite narrowing of the optic canal in fibrous dysplasiaJanice S Lee, Edmond FitzGibbon, John A Butman, et al.
Pediatric Transplantation|July 29, 2005
Idiopathic intracranial hypertension following kidney transplantation: a case report and review of the literatureChristine E Chamberlain, Edmond Fitzgibbon, Eric M Wassermann, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2021
Survivorship Issues in Adult Patients With Histiocytic NeoplasmsKevin O'Brien, Rahul Dave, Skand Shekhar, et al.
Ophthalmology|June 25, 2021
ReplyM Teresa Magone, Iris R Hartley, Edmond FitzGibbon, et al.
Ophthalmology|September 5, 2020
Ocular Adverse Effects of Infigratinib, a New Fibroblast Growth Factor Receptor Tyrosine Kinase InhibitorM Teresa Magone, Iris R Hartley, Edmond Fitzgibbon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 31, 2020
Outcomes in Previously Healthy Cryptococcal Meningoencephalitis Patients Treated With Pulse Taper Corticosteroids for Post-infectious Inflammatory SyndromeSeher Anjum, Owen Dean, Peter Kosa, et al.
JAMA|March 18, 2024
Clinical, Biomarker, and Research Tests Among US Government Personnel and Their Family Members Involved in Anomalous Health IncidentsLeighton Chan, Mark Hallett, Chris K Zalewski, et al.
Pageof 1